High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.

Por Yeh, K. H., Cheng, A. L.
Publicado em 1997

Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil

Por Yeh, K-H, Yeh, S-H, Hsu, C-H, Wang, T-M, Ma, I-F, Cheng, A-L
Publicado em 2000

An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer

Por Chao, Y, Li, C P, Chao, T Y, Su, W C, Hsieh, R K, Wu, M F, Yeh, K H, Kao, W Y, Chen, L T, Cheng, A L
Publicado em 2006

Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer

Por Yeh, K H, Lu, Y S, Hsu, C H, Lin, J F, Chao, H J, Huang, T C, Chung, C Y, Chang, C S, Yang, C H, Cheng, A L
Publicado em 2005

Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity

Por Kuo, S-H, Yeh, K-H, Chen, L-T, Lin, C-W, Hsu, P-N, Hsu, C, Wu, M-S, Tzeng, Y-S, Tsai, H-J, Wang, H-P, Cheng, A-L
Publicado em 2014

Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract

Por Hsu, C, Shen, Y-C, Yang, C-H, Yeh, K-H, Lu, Y-S, Hsu, C-H, Liu, H-T, Li, C-C, Chen, J-S, Wu, C-Y, Cheng, A-L
Publicado em 2004

Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significance

Por Kuo, S-H, Chen, L-T, Lin, C-W, Wu, M-S, Hsu, P-N, Tsai, H-J, Chu, C-Y, Tzeng, Y-S, Wang, H-P, Yeh, K-H, Cheng, A-L
Publicado em 2013

Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

Por Chang, T. C., Shiah, H. S., Yang, C. H., Yeh, K. H., Cheng, A. L., Shen, B. N., Wang, Y. W., Yeh, C. G., Chiang, N. J., Chang, J. Y., Chen, L. T.
Publicado no Cancer Chemother Pharmacol (2015)

Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer

Por Chao, Y, Yeh, K H, Chang, C J, Chen, L T, Chao, T Y, Wu, M F, Chang, C S, Chang, J Y, Chung, C Y, Kao, W Y, Hsieh, R K, Cheng, A L
Publicado em 2004

A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies

Por Lin, C-C, Su, W-C, Yen, C-J, Hsu, C-H, Su, W-P, Yeh, K-H, Lu, Y-S, Cheng, A-L, Huang, D C-L, Fritsch, H, Voss, F, Taube, T, Yang, J C-H
Publicado em 2014